The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

Archive ouverte

Viaud, Sophie | Saccheri, Fabiana | Mignot, Gregoire | Yamazaki, Takahiro | Daillere, Romain | Hannani, Dalil | Enot, David P. | Pfirschke, Christina | Engblom, Camilla | Pittet, Mikael J. | Schlitzer, Andreas | Ginhoux, Florent | Apetoh, Lionel | Chachaty, Elisabeth | Woerther, Paul-Louis | Eberl, Gerard | Berard, Marion | Ecobichon, Chantal | Clermont, Dominique | Bizet, Chantal | Gaboriau-Routhiau, Valerie | Cerf-Bensussan, Nadine | Opolon, Paule | Yessaad, Nadia | Vivier, Eric | Ryffel, Bernhard | Elson, Charles O. | Dore, Joel | Kroemer, Guido | Lepage, Patricia | Boneca, Ivo Gomperts | Ghiringhelli, Francois | Zitvogel, Laurence

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

Cyclophosphamide is one of several clinically important cancer drugs whose therapeutic efficacy is due in part to their ability to stimulate antitumor immune responses. Studying mouse models, we demonstrate that cyclophosphamide alters the composition of microbiota in the small intestine and induces the translocation of selected species of Gram-positive bacteria into secondary lymphoid organs. There, these bacteria stimulate the generation of a specific subset of "pathogenic" T helper 17 (pT(H)17) cells and memory T(H)1 immune responses. Tumor-bearing mice that were germ-free or that had been treated with antibiotics to kill Gram-positive bacteria showed a reduction in pT(H)17 responses, and their tumors were resistant to cyclophosphamide. Adoptive transfer of pT(H)17 cells partially restored the antitumor efficacy of cyclophosphamide. These results suggest that the gut microbiota help shape the anticancer immune response.

Consulter en ligne

Suggestions

Du même auteur

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Archive ouverte | Vétizou, Marie | CCSD

International audience. Antibodies targeting CTLA-4 have been successfully used as cancer immunotherapy. We find that the antitumor effects of CTLA-4 blockade depend on distinct Bacteroides species. In mice and pati...

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

Archive ouverte | Daillère, Romain | CCSD

International audience. The efficacy of the anti-cancer immunomodulatory agent cyclophosphamide (CTX) relies on intestinal bacteria. How and which relevant bacterial species are involved in tumor immunosurveillance,...

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Archive ouverte | Sistigu, Antonella | CCSD

International audience. The immune system is routinely confronted with cell death resulting from the physiological turnover of renewable tissues, as well as from pathological insults of several types. We hypothesize...

Chargement des enrichissements...